echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Jincheng Pharmaceutical's posaconazole API registration application was approved by CDE

    Jincheng Pharmaceutical's posaconazole API registration application was approved by CDE

    • Last Update: 2022-03-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the evening of February 14, Jincheng Pharmaceutical announced that its wholly-owned subsidiary Shandong Jincheng Bio was inquired on the CDE "Original and Auxiliary Package Registration Information" publicity platform and learned that the registration application for "posaconazole" API submitted by it was approved by the CDE.

    .

    Posaconazole is a second-generation triazole antifungal drug mainly used to prevent invasive Aspergillus and Candida infections
    .


    Posaconazole preparations include oral suspensions, enteric-coated tablets and injections, all of which have been approved for marketing in China


    At present, through the original auxiliary package registration information platform of the State Food and Drug Administration, the posaconazole APIs of 2 companies including Jincheng Bio have been approved


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.